Richard T Hoppe

Richard T Hoppe

UNVERIFIED PROFILE

Are you Richard T Hoppe?   Register this Author

Register author
Richard T Hoppe

Richard T Hoppe

Publications by authors named "Richard T Hoppe"

Are you Richard T Hoppe?   Register this Author

100Publications

2968Reads

25Profile Views

Keep the Dose Low. Keep the Fields Tight.

Authors:
Richard T Hoppe

Int J Radiat Oncol Biol Phys 2020 Jan;106(1):15

Department of Radiation Oncology, Stanford University; Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2018.04.022DOI Listing
January 2020

Tomayto, tomahto: prescription dose and mean heart dose in evaluating the cardiac impact of involved-field radiation therapy for Hodgkin lymphoma survivors.

Acta Oncol 2019 Dec 6;58(12):1783-1785. Epub 2019 Sep 6.

Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2019.1657943DOI Listing
December 2019

Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin.

J Am Acad Dermatol 2019 Oct 29;81(4):970-976. Epub 2019 Jan 29.

Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2019.01.037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661219PMC
October 2019

The Meaningless Meaning of Mean Heart Dose in Mediastinal Lymphoma in the Modern Radiation Therapy Era.

Pract Radiat Oncol 2019 Oct 2. Epub 2019 Oct 2.

University of Florida Health Proton Therapy Institute, Jacksonville, Florida; Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2019.09.015DOI Listing
October 2019

20 Gy Versus 30 Gy: Will it Make a Difference?

Authors:
Richard T Hoppe

Int J Radiat Oncol Biol Phys 2019 09;105(1):102-103

Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2019.06.008DOI Listing
September 2019

Remarkable Advances in the Management of Mycosis Fungoides and the Sezary Syndrome.

Authors:
Richard T Hoppe

Oncol Res Treat 2017 20;40(5):242-243. Epub 2017 Apr 20.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000475528DOI Listing
August 2019

Low-dose total skin electron beam therapy for refractory cutaneous CD30 positive lymphoproliferative disorders.

J Dermatolog Treat 2019 Jun 27:1-3. Epub 2019 Jun 27.

a Department of Radiation Oncology , Stanford University , Stanford , CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/09546634.2019.1628913DOI Listing
June 2019

Volumetric Modulated Arc Therapy and 3-Dimensional Printed Bolus in the Treatment of Refractory Primary Cutaneous Gamma Delta Lymphoma of the Bilateral Legs.

Pract Radiat Oncol 2019 Jul - Aug;9(4):220-225. Epub 2019 Mar 2.

Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2019.02.016DOI Listing
March 2019

Prognostic factors and patterns of failure in advanced stage Hodgkin lymphoma treated with combined modality therapy.

Radiother Oncol 2018 12 6;129(3):507-512. Epub 2018 Jul 6.

Department of Radiation Oncology, Stanford University School of Medicine, Stanford, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2018.06.033DOI Listing
December 2018

Allogeneic transplantation using TLI-ATG conditioning for Hodgkin lymphoma after failure of autologous transplantation.

Blood Adv 2018 07;2(13):1547-1550

Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2018021071DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039652PMC
July 2018

Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee.

Int J Radiat Oncol Biol Phys 2017 11 21;99(4):825-842. Epub 2017 Sep 21.

Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida; University of Florida Health Proton Therapy Institute, Jacksonville, Florida. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.05.004DOI Listing
November 2017

Post-treatment surveillance imaging in lymphoma.

Semin Oncol 2017 10 3;44(5):310-322. Epub 2018 Feb 3.

Department of Radiation Oncology, Stanford University, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2018.01.008DOI Listing
October 2017

Localized skin-limited blastic plasmacytoid dendritic cell neoplasm: A subset with possible durable remission without transplantation.

JAAD Case Rep 2017 Jul 19;3(4):310-315. Epub 2017 Jul 19.

Department of Dermatology, Stanford Cancer Center, Stanford Hospital and Clinics, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdcr.2017.03.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517837PMC
July 2017

Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations.

J Natl Cancer Inst 2017 04 31;109(4). Epub 2016 Dec 31.

Affiliations of authors: NYU Perlmutter Cancer Center, New York, NY (CSD); BC Cancer Agency Centre for Lymphoid Cancer, Vancouver, BC, Canada (JMC); Wilmot Cancer Center and Division of Hematology/Oncology, University of Rochester Medical Center, Rochester, NY (JWF); Department of Medicine, Weil Cornell University, New York, NY (JPL); Oncology Division, Department of Medicine, Washington University, St. Louis, MO (BSK, NLB); Division of Cancer Treatment and Diagnosis (RFL) and Coordinating Center for Clinical Trials (LB), Tufts Cancer Center and Division of Hematology/Oncology, Tufts University School of Medicine, Boston, MA (AME); Stanford Cancer Institute, Stanford University Medical School, Stanford, CA (RTH); Division of Pediatric Hematology/Oncology/Stem Cell Transplant, Columbia University Medical Center, New York, NY (KMK); Department of Medicine, University of Arizona Cancer Center, Tucson, AZ (DOP); Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY (AY); Department of Radiology, Mount Sinai Hospital, New York, NY (LK).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw249DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059238PMC
April 2017

Partial orbit irradiation achieves excellent outcomes for primary orbital lymphoma.

Pract Radiat Oncol 2016 Jul-Aug;6(4):255-61. Epub 2015 Nov 22.

Department of Radiation Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2015.11.013DOI Listing
March 2017

A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.

Leuk Lymphoma 2016 28;57(3):604-8. Epub 2015 Aug 28.

a Department of Radiation Oncology , Stanford University School of Medicine , Stanford , CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1067700DOI Listing
December 2016

2 Gy × 2 for palliative treatment of mantle cell lymphoma.

Leuk Lymphoma 2016 09 14;57(9):2219-21. Epub 2016 Jan 14.

a Department of Radiation Oncology , Stanford Cancer Institute, Stanford University , Stanford , CA , USA ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1131274DOI Listing
September 2016

NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.

J Natl Compr Canc Netw 2016 09;14(9):1067-79

From Memorial Sloan Kettering Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; The University of Texas MD Anderson Cancer Center; Massachusetts General Hospital Cancer Center; Stanford Cancer Institute; UCSF Helen Diller Family Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Fox Chase Cancer Center; Huntsman Cancer Institute at the University of Utah; Mayo Clinic Cancer Center; Roswell Park Cancer Institute; University of Michigan Comprehensive Cancer Center; Duke Cancer Institute; Consultant; Dana-Farber/Brigham and Women's Cancer Center; Fred & Pamela Buffett Cancer Center; City of Hope Comprehensive Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; University of Colorado Cancer Center; Vanderbilt-Ingram Cancer Center; UC San Diego Moores Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Alabama at Birmingham Comprehensive Cancer Center; Moffitt Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; St. Jude Children's Research Hospital/University of Tennessee Health Science Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0117DOI Listing
September 2016

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome.

J Clin Oncol 2016 08 11;34(23):2690-7. Epub 2016 Apr 11.

Margaretha G.M. Roemer, Robert A. Redd, Heather Homer, Courtney F. Connelly, Gordon J. Freeman, Philippe Armand, Bjoern Chapuy, Donna S. Neuberg, and Margaret A. Shipp, Dana-Farber Cancer Institute; Azra H. Ligon, Heather H. Sun, and Scott J. Rodig, Brigham and Women's Hospital, Boston, MA; Margaretha G.M. Roemer and Daphne de Jong, VU University Medical Center, Amsterdam, the Netherlands; and Ranjana H. Advani, Yasodha Natkunam, Sarah E. Daadi, and Richard T. Hoppe, Stanford University Medical Center, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.4482DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019753PMC
August 2016

Re-Examining the Role of Radiation Therapy for Diffuse Large B-Cell Lymphoma in the Modern Era.

J Clin Oncol 2016 May 22;34(13):1443-7. Epub 2016 Feb 22.

Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.9418DOI Listing
May 2016

Breast Imaging in Women Previously Irradiated for Hodgkin Lymphoma.

Am J Clin Oncol 2016 Apr;39(2):114-9

Departments of *Radiation Oncology †Medicine ‡Radiology, Division of Medical Oncology, Stanford University School of Medicine, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079764PMC
April 2016

Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project.

J Clin Oncol 2015 Nov 20;33(32):3750-8. Epub 2015 Jul 20.

Youn H. Kim, Mahkam Tavallaee, Uma Sundram, Shufeng Li, Sima Rozati, Seema Nagpal, Michael Krathen, Sunil Reddy, Richard T. Hoppe, Annie Nguyen-Lin, Wen-Kai Weng, Randall Armstrong, and Ranjana H. Advani, Stanford University, Stanford, CA; Katrin A. Salva and Gary S. Wood, University of Wisconsin and William S. Middleton Memorial Veterans Hospital, Madison, WI; and Melissa Pulitzer and Steven M. Horwitz, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.3969DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089160PMC
November 2015

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.

J Clin Oncol 2015 Nov 5;33(32):3766-73. Epub 2015 Oct 5.

Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.7142DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979132PMC
November 2015

Hodgkin Lymphoma: the Changing Role of Radiation Therapy in Early-Stage Disease—the Role of Functional Imaging.

Curr Treat Options Oncol 2015 Sep;16(9):45

Department of Medicine, Divisions of Hematology and Oncology, Stanford University Medical Center, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-015-0360-6DOI Listing
September 2015

Biological characterization of stage I follicular lymphoma according to extranodal or nodal primary origin and t(14;18) status using high-resolution array-based comparative genomic hybridization.

Am J Hematol 2015 Aug 29;90(8):E151-2. Epub 2015 May 29.

Department of Pathology, Stanford University Medical Center, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24050DOI Listing
August 2015

Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial.

J Clin Oncol 2015 Jun 20;33(17):1936-42. Epub 2015 Apr 20.

Ranjana H. Advani, Richard T. Hoppe, and Sandra J. Horning, Stanford University, Stanford; Joseph M. Tuscano, University of California, Davis Cancer Center, Sacramento, CA; Fangxin Hong, Dana-Farber Cancer Institute, Boston, MA; Richard I. Fisher and Jonathan W. Friedberg, University of Rochester, Rochester, NY; Nancy L. Bartlett, Washington University School of Medicine, St Louis, MO; K. Sue Robinson, Queen Elizabeth II Health Science Center, Halifax, Nova Scotia; Randy D. Gascoyne, British Columbia Cancer Agency, Vancouver, British Columbia; Douglas A. Stewart, Tim Baker Cancer Institute, Calgary, Alberta, Canada; Henry Wagner Jr, Penn State Cancer Institute, Hershey, PA; Patrick J. Stiff, Loyola University Medical Center, Maywood; Leo I. Gordon, Northwestern University, Chicago, IL; Bruce D. Cheson, Georgetown University Hospital, Washington, DC; Brad S. Kahl, University of Wisconsin, Madison, WI; Kristie A. Blum, Ohio State University, Columbus, OH; and Thomas M. Habermann, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/04/15/JCO.2014.57
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.57.8138
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.57.8138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451176PMC
June 2015

XVIII. Management of nodular lymphocyte predominant Hodgkin lymphoma.

Hematol Oncol 2015 Jun;33 Suppl 1:90-5

Stanford Cancer Institute, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2226DOI Listing
June 2015

The Paris conference "La Radiothérapie de la Maladie de Hodgkin": a first step in the cure of Hodgkin disease.

Int J Radiat Oncol Biol Phys 2015 May;92(1):3-4

Department of Radiation Oncology, Stanford University, Stanford, California; Department of Medicine, Stanford University, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2015.01.027DOI Listing
May 2015

Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group.

Int J Radiat Oncol Biol Phys 2015 May;92(1):11-31

Division of Radiation Oncology, Peter MacCallum Cancer Institute, St. Andrews Place, East Melbourne, Australia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03603016150005
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2015.01.009DOI Listing
May 2015

Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group.

Int J Radiat Oncol Biol Phys 2015 May;92(1):32-9

Department of Radiation Oncology, Stanford University, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2015.01.008DOI Listing
May 2015

Expert radiation oncologist interpretations of involved-site radiation therapy guidelines in the management of Hodgkin lymphoma.

Int J Radiat Oncol Biol Phys 2015 May;92(1):40-5

Stanford Cancer Institute, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2015.02.008DOI Listing
May 2015

Management of nodular lymphocyte predominant Hodgkin lymphoma in the modern era.

Int J Radiat Oncol Biol Phys 2015 May;92(1):67-75

Department of Radiation Oncology, Stanford Cancer Institute, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2015.02.001DOI Listing
May 2015

Value of surveillance studies for patients with stage I to II diffuse large B-cell lymphoma in the rituximab era.

Int J Radiat Oncol Biol Phys 2015 May;92(1):99-106

Department of Radiation Oncology, Stanford Cancer Institute, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2015.01.039DOI Listing
May 2015

Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).

Int J Radiat Oncol Biol Phys 2014 Jul 18;89(4):854-62. Epub 2013 Jun 18.

Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard University, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2013.05.005DOI Listing
July 2014

Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma.

J Clin Oncol 2014 Mar 10;32(9):912-8. Epub 2014 Feb 10.

Ranjana H. Advani, Sandra J. Horning, Richard T. Hoppe, Sarah Daadi, John Allen, and Yasodha Natkunam, Stanford University Medical Center, Stanford, CA; and Nancy L. Bartlett, Washington University School of Medicine, St Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.2069DOI Listing
March 2014

Bulky mediastinal classical Hodgkin lymphoma in young women.

Oncology (Williston Park) 2014 Mar;28(3):253-6, 258-60, C3

View Article

Download full-text PDF

Source
March 2014

How I treat nodular lymphocyte predominant Hodgkin lymphoma.

Blood 2013 Dec 8;122(26):4182-8. Epub 2013 Nov 8.

Medical Oncology, and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-07-453241DOI Listing
December 2013

Low-dose radiation therapy (2 Gy × 2) in the treatment of orbital lymphoma.

Int J Radiat Oncol Biol Phys 2013 Aug 29;86(5):930-5. Epub 2013 May 29.

Department of Radiation Oncology, Stanford University, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2013.04.035DOI Listing
August 2013

Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy.

Hematology Am Soc Hematol Educ Program 2012 ;2012:313-21

1National Cancer Institute of Canada (NCIC) Clinical Trials Group, Queen’s University, Kingston, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2012.1.313DOI Listing
June 2013

Evolution of the techniques of radiation therapy in the management of lymphoma.

Authors:
Richard T Hoppe

Int J Clin Oncol 2013 Jun 11;18(3):359-63. Epub 2013 Apr 11.

Department of Radiation Oncology, Stanford University, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-013-0556-3DOI Listing
June 2013

Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy.

Blood 2012 Nov 20;120(23):4488-95. Epub 2012 Jul 20.

National Cancer Institute of Canada (NCIC) Clinical Trials Group, Queen's University, Kingston, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-05-423236DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512228PMC
November 2012

Long-term outcomes after high dose therapy and autologous haematopoietic cell rescue for refractory/relapsed Hodgkin lymphoma.

Br J Haematol 2012 Nov 12;159(3):329-39. Epub 2012 Sep 12.

Department of Radiation Oncology, Stanford University, Palo Alto, CA, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.12038
Publisher Site
http://dx.doi.org/10.1111/bjh.12038DOI Listing
November 2012

A tribute to Malcolm A. Bagshaw--an innovative physician who soared to success.

Int J Radiat Oncol Biol Phys 2012 May;83(1):6-7

Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2012.02.010DOI Listing
May 2012

Interim-treatment quantitative PET parameters predict progression and death among patients with Hodgkin's disease.

Radiat Oncol 2012 Jan 19;7. Epub 2012 Jan 19.

Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wilbur Dr., Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1748-717X-7-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398283PMC
January 2012

Stage I-IIA non-bulky Hodgkin's lymphoma. Is further distinction based on prognostic factors useful? The Stanford experience.

Int J Radiat Oncol Biol Phys 2011 Dec 8;81(5):1374-9. Epub 2010 Oct 8.

Department of Medicine, Division of Medical Oncology, Stanford University Medical Center, Stanford, California 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2010.07.041DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020265PMC
December 2011

Treatment strategies in limited stage follicular NHL.

Authors:
Richard T Hoppe

Best Pract Res Clin Haematol 2011 Jun 13;24(2):179-86. Epub 2011 Apr 13.

Department of Radiation Oncology, 875 Blake Wilbur Drive, Room CC-G224, Stanford University, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2011.02.008DOI Listing
June 2011

How I treat mycosis fungoides and Sézary syndrome.

Blood 2009 Nov 20;114(20):4337-53. Epub 2009 Aug 20.

Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2009-07-20
Publisher Site
http://dx.doi.org/10.1182/blood-2009-07-202895DOI Listing
November 2009

Indolent primary cutaneous B-cell lymphoma: experience using systemic rituximab.

J Am Acad Dermatol 2008 Dec 24;59(6):953-7. Epub 2008 Sep 24.

Multidisciplinary Cutaneous Lymphoma Program, Stanford Comprehensive Cancer Center, Stanford, California 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2008.08.005DOI Listing
December 2008

Clinicopathologic features and treatment outcomes in Woringer-Kolopp disease.

J Am Acad Dermatol 2008 Oct 11;59(4):706-12. Epub 2008 Jun 11.

Department of Dermatology, Stanford University School of Medicine, Stanford, California 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2008.04.018DOI Listing
October 2008

Tolerance and chimerism after renal and hematopoietic-cell transplantation.

N Engl J Med 2008 Jan;358(4):362-8

Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa074191DOI Listing
January 2008

Hodgkin's lymphoma: the role of radiation in the modern combined strategies of treatment.

Authors:
Richard T Hoppe

Hematol Oncol Clin North Am 2007 Oct;21(5):915-27

Department of Radiation Oncology, Stanford University, 875 Blake Wilbur Drive, Room CC-G224, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2007.06.013DOI Listing
October 2007

Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease.

J Clin Oncol 2007 Jan;25(1):43-9

Department of Medicine, Division of Cardiology, Stanford University Medical Center, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.07.0805DOI Listing
January 2007

Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.

Arch Dermatol 2007 Jan;143(1):45-50

Department of Dermatology, Stanford University School of Medicine, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archderm.143.1.45DOI Listing
January 2007